Abstract
Eating disorders (EDs) are serious illnesses whose treatment, particularly with children and adolescents, requires sophisticated integration of skills and techniques from the armamentarium of evidence-based treatments targeting EDs and associated symptoms. Especially difficult to treat are cognitive impairments, because they are both disease specific (e.g., cognitive distortions related to the body itself) and more general (e.g., difficulties with uncertainty). This paper discusses cognitive impairments in EDs that involve difficulty coping with uncertainty and the associated implications on emotional and behavioral functioning. A set of skills to assess and increase adaptive coping with uncertainty is discussed in depth. Clinicians are strongly encouraged to target cognitive difficulties such as intolerance of uncertainty in ED treatment, as they can otherwise significantly interfere with one of the strongest predictors of successful outcomes - behavior change.
Keywords: Eating disorders, anorexia nervosa, intolerance of uncertainty, psychotherapy, cognitive therapy, behavioral therapy, acceptance and commitment therapy, mindfulness, meditation, breathwork
Adolescent Psychiatry
Title: Difficulty with Uncertainty: How It Presents in Eating Disorders and What We Can Do About it
Volume: 1 Issue: 4
Author(s): Maria-Christina Stewart
Affiliation:
Keywords: Eating disorders, anorexia nervosa, intolerance of uncertainty, psychotherapy, cognitive therapy, behavioral therapy, acceptance and commitment therapy, mindfulness, meditation, breathwork
Abstract: Eating disorders (EDs) are serious illnesses whose treatment, particularly with children and adolescents, requires sophisticated integration of skills and techniques from the armamentarium of evidence-based treatments targeting EDs and associated symptoms. Especially difficult to treat are cognitive impairments, because they are both disease specific (e.g., cognitive distortions related to the body itself) and more general (e.g., difficulties with uncertainty). This paper discusses cognitive impairments in EDs that involve difficulty coping with uncertainty and the associated implications on emotional and behavioral functioning. A set of skills to assess and increase adaptive coping with uncertainty is discussed in depth. Clinicians are strongly encouraged to target cognitive difficulties such as intolerance of uncertainty in ED treatment, as they can otherwise significantly interfere with one of the strongest predictors of successful outcomes - behavior change.
Export Options
About this article
Cite this article as:
Stewart Maria-Christina, Difficulty with Uncertainty: How It Presents in Eating Disorders and What We Can Do About it, Adolescent Psychiatry 2011; 1 (4) . https://dx.doi.org/10.2174/2210676611101040296
DOI https://dx.doi.org/10.2174/2210676611101040296 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preeclampsia and the Future Development of Cardiovascular Disease: A Review
Current Women`s Health Reviews Analytical Methods for Determination of CO and CO2 and their Applicability in Biological Studies
Current Pharmaceutical Analysis Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes
Clinical Cancer Drugs Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace
Adolescent Psychiatry How to Assess Sympathetic Nervous System Activity in Clinical Practice
Current Clinical Pharmacology Properties and Therapeutic Potential of Transient Receptor Potential Channels with Putative Roles in Adversity: Focus on TRPC5, TRPM2 and TRPA1
Current Drug Targets Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors
Current Pharmaceutical Design Small Heat Shock Proteins (sHSPs) As Potential Drug Targets
Current Pharmaceutical Biotechnology Telocytes in Liver
Current Stem Cell Research & Therapy Biobanking in Atherosclerotic Disease, Opportunities and Pitfalls
Current Cardiology Reviews Acid-Sensing Ion Channels Structural Aspects, Pathophysiological Importance and Experimental Mutational Data Available Across Various Species to Target Human ASIC1
Current Drug Targets Heart Failure Models: Traditional and Novel Therapy
Current Vascular Pharmacology Engineering Three-Dimensional Cardiac Microtissues for Potential Drug Screening Applications
Current Medicinal Chemistry Trimetazidine Dihydrochloride Pulsatile–Release Tablets for the Treatment of Morning Anginal Symptoms: Dual Optimization, Characterization and Pharmacokinetic Evaluation
Current Drug Delivery The Benefits of Exercise and Metabolic Interventions for the Prevention and Early Treatment of Alzheimer's Disease
Current Alzheimer Research Role of Astrocytes, Soluble Factors, Cells Adhesion Molecules and Neurotrophins in Functional Synapse Formation: Implications for Human Embryonic Stem Cell Derived Neurons
Current Stem Cell Research & Therapy An Engrossing History of Azidothymidine
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Adverse Drug Reactions in Critical Care Settings: A Systematic Review
Current Drug Safety Susceptibility Genes in Hypertension
Current Pharmaceutical Design Circulating Biomarkers of Collagen Metabolism and Prognosis of Heart Failure with Reduced or Mid-Range Ejection Fraction
Current Pharmaceutical Design